Clinical trial
Multicenter, Evaluator-blind, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of JUVÉDERM® VOLITE™ for Correction of Perioral Lines in Chinese Population
NCT05454033 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Evaluator-blind, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of JUVÉDERM® VOLITE™ for Correction of Perioral Lines in Chinese Population
- Lead sponsor
- AbbVie
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 7, 2022
- Completion date
- September 3, 2024
- Enrollment
- 198 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
perioral lines